Drawing for TUMORMAPR

USPTO serial 87804771

TUMORMAPR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GOLDEN, LAURA DAWN
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TUMORMAPR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Summerfield

Victoria Summerfield Pepper Hamilton LLP3000 Two Logan SquarePhiladelphia, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software for use in the medical field of pathology featuring web based pathology software, namely, web based image analysis software for use in the field of pathology to interpret patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; SAAS services featuring software for use in the field of pathology, namely, software that defines the spatial relationship between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples to interpret patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and analyze the spatial interactions of biomarkers; SAAS services featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy to interpret patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and analyze the spatial interactions of biomarkers; SAAS services featuring software for viewing and managing images and for digital pathology image management to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; SAAS services featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; SAAS services featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trails in the field of pathology; SAAS services featuring web based software for remotely managing pathology images, for remotely managing pathology images and metadata, and for creating, assigning, and managing pathology cases; SAAS services featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; SAAS services featuring computer software for tissue-based image analysis algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; and SAAS services featuring data-processing software for tissue-based image analysis using algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnosticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 21, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 21, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 8, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 8, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 8, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 3, 2019DOCKASSIGNED TO EXAMINER—
Nov 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 11, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 8, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 25, 2019PBSRWITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST—
Feb 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 13, 2018PBTQWITHDRAWN FROM PUB OTQR REQUEST—
Jul 2, 2018ALIEASSIGNED TO LIE—
Jun 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jun 15, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 15, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 15, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 6, 2018DOCKASSIGNED TO EXAMINER—
Feb 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance